PCBL Chemical (PCBL)₹277.75−1.51%Carbon Black
In the Jun 2026 quarter (consolidated), PCBL Chemical reported sales of ₹2,465 Cr, up 17.0% from Jun 2025, and net profit of ₹155 Cr, up 64.9% year on year. For the year to Mar 2026, sales were ₹8,167 Cr and net profit ₹198 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,483 | 1,653 | 1,925 | 2,138 | 2,158 | 2,005 | 2,081 | 2,108 | 2,159 | 1,843 | 2,061 | 2,465 |
| Expenses | 1,254 | 1,384 | 1,625 | 1,793 | 1,807 | 1,699 | 1,797 | 1,802 | 1,905 | 1,637 | 1,830 | 2,086 |
| Operating Profit | 238 | 279 | 311 | 358 | 364 | 318 | 298 | 320 | 266 | 215 | 244 | 396 |
| OPM % | 16.0% | 17.0% | 15.9% | 17.0% | 17.0% | 16.0% | 14.0% | 14.9% | 11.9% | 12.0% | 12.0% | 16.0% |
| Other Income | 3.01 | 7.01 | 23.04 | 11.01 | 6.01 | 11.02 | 20.03 | 6.01 | 12.01 | −5.01 | 0.00 | 4.01 |
| Interest | 21.07 | 32.13 | 108 | 121 | 119 | 118 | 103 | 112 | 107 | 106 | 97.33 | 93.38 |
| Depreciation | 47.99 | 53.04 | 74.96 | 84.07 | 85.99 | 87.01 | 87.97 | 91.95 | 92.95 | 93.96 | 94.06 | 103 |
| Profit before tax | 172 | 201 | 149 | 164 | 164 | 124 | 126 | 120 | 78.14 | 10.01 | 52.04 | 204 |
| Tax % | 28.0% | 26.0% | 26.0% | 28.0% | 25.0% | 25.0% | 21.0% | 22.0% | 21.0% | 80.0% | 23.0% | 24.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −3.01 | −3.01 | 0.00 |
| Net Profit | 123 | 148 | 111 | 118 | 123 | 92.91 | 99.86 | 93.88 | 61.93 | 1.99 | 39.97 | 155 |
| EPS (Rs) | 3.26 | 3.93 | 2.96 | 3.14 | 3.28 | 2.48 | 2.66 | 2.50 | 1.64 | 0.06 | 1.03 | 3.96 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,891 | 1,924 | 2,551 | 3,521 | 3,236 | 2,652 | 4,438 | 5,763 | 6,407 | 8,379 | 8,167 | 8,527 |
| Expenses | 1,735 | 1,667 | 2,183 | 2,925 | 2,788 | 2,150 | 3,807 | 5,064 | 5,402 | 7,095 | 7,175 | 7,459 |
| Operating Profit | 165 | 266 | 384 | 618 | 466 | 518 | 655 | 732 | 1,039 | 1,339 | 1,045 | 1,122 |
| OPM % | 9.0% | 14.0% | 15.0% | 17.0% | 14.0% | 19.0% | 15.0% | 13.0% | 15.9% | 16.0% | 13.0% | 13.2% |
| Other Income | 16.02 | 12.01 | 23.04 | 20.04 | 28.04 | 19.01 | 28.04 | 41.07 | 37.06 | 47.08 | 14.01 | 11.01 |
| Interest | 72.27 | 51.15 | 41.14 | 37.14 | 46.15 | 34.09 | 29.09 | 53.18 | 182 | 462 | 424 | 404 |
| Depreciation | 62.04 | 61.03 | 61.01 | 66.02 | 92.02 | 110 | 121 | 137 | 217 | 346 | 373 | 384 |
| Profit before tax | 47.04 | 165 | 304 | 534 | 356 | 393 | 533 | 583 | 677 | 578 | 261 | 345 |
| Tax % | 66.0% | 58.0% | 24.0% | 28.0% | 19.0% | 20.0% | 20.0% | 24.0% | 27.0% | 25.0% | 24.0% | — |
| Exceptional items | 1.01 | 1.01 | 2.01 | 6.02 | 7.01 | 3.01 | 7.02 | 0.00 | 0.00 | 2.01 | −17.03 | −6.02 |
| Net Profit | 15.99 | 68.97 | 230 | 382 | 288 | 314 | 425 | 442 | 491 | 434 | 198 | 259 |
| EPS (Rs) | 0.47 | 2.02 | 6.66 | 11.17 | 8.34 | 9.13 | 11.33 | 11.73 | 13.06 | 11.55 | 5.05 | 6.69 |
| Dividend payout % | 54.0% | 30.0% | 10.9% | 16.0% | 42.0% | 38.0% | 44.0% | 47.0% | 42.0% | 48.0% | 119.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 34.05 | 34.03 | 34.06 | 34.07 | 34.02 | 34.01 | 34.03 | 38.04 | 38.02 | 38.03 | 38.01 | 39.07 |
| Reserves | 471 | 1,007 | 1,092 | 1,339 | 1,610 | 1,660 | 1,894 | 2,568 | 2,782 | 3,198 | 3,648 | 3,956 |
| Borrowings | 1,221 | 1,022 | 759 | 717 | 793 | 617 | 724 | 786 | 1,030 | 4,986 | 5,571 | 4,992 |
| Other Liabilities | 285 | 527 | 694 | 780 | 949 | 1,000 | 1,072 | 1,392 | 1,581 | 3,077 | 2,465 | 2,310 |
| Total Liabilities | 2,011 | 2,590 | 2,580 | 2,870 | 3,386 | 3,310 | 3,725 | 4,784 | 5,431 | 11,298 | 11,722 | 11,298 |
| Fixed Assets | 852 | 1,418 | 1,389 | 1,400 | 1,502 | 1,642 | 1,744 | 1,936 | 1,971 | 6,904 | 6,603 | 7,156 |
| CWIP | 79.89 | 79.95 | 79.95 | 66.96 | 175 | 306 | 267 | 175 | 1,129 | 433 | 732 | 566 |
| Investments | 86.14 | 228 | 291 | 316 | 363 | 155 | 196 | 589 | 234 | 433 | 517 | 465 |
| Other Assets | 993 | 865 | 821 | 1,088 | 1,347 | 1,207 | 1,518 | 2,083 | 2,097 | 3,528 | 3,870 | 3,110 |
| Inventories | 296 | 243 | 243 | 309 | 458 | 325 | 444 | 601 | 569 | 995 | 1,262 | 1,021 |
| Trade receivables | 523 | 440 | 468 | 524 | 656 | 590 | 711 | 1,110 | 1,115 | 1,716 | 1,802 | 1,400 |
| Cash & equivalents | 12.99 | 51.92 | 24.97 | 173 | 115 | 152 | 264 | 159 | 95.86 | 384 | 389 | 288 |
| Total Assets | 2,011 | 2,590 | 2,580 | 2,870 | 3,386 | 3,310 | 3,725 | 4,784 | 5,431 | 11,298 | 11,722 | 11,298 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 34.99 | 422 | 346 | 293 | 290 | 532 | 385 | 290 | 503 | 1,103 | 760 | 1,575 |
| Cash from investing activity | −68.05 | −121 | −36.01 | −33.99 | −278 | −107 | −203 | −542 | −553 | −4,218 | −691 | −676 |
| Cash from financing activity | 34.01 | −262 | −337 | −110 | −70.01 | −389 | −180 | 217 | −31.03 | 3,382 | −64.04 | −990 |
| Net cash flow | 0.99 | 38.86 | −26.92 | 148 | −57.82 | 35.87 | 2.99 | −33.91 | −77.82 | 271 | 5.98 | −88.68 |
| Capex | 34.10 | 39.07 | 41.09 | 94.18 | 233 | 231 | 115 | 307 | 899 | 537 | 776 | 728 |
| Free cash flow | 1.99 | 387 | 306 | 198 | 57.95 | 301 | 270 | −15.97 | −391 | 572 | −3.99 | 850 |
| CFO / OP % | 24.0% | 262.1% | 143.1% | 94.1% | 68.1% | 129.1% | 87.1% | 60.0% | 92.0% | 127.1% | 70.1% | 158.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 76 | 83 | 87 | 73 | 67 | 65 | 96 | 90 | 69 | 96 | 77 | 61 |
| Inventory days | 55 | 65 | 71 | 67 | 72 | 53 | 100 | 69 | 47 | 81 | 79 | 64 |
| Days payable | 27 | 73 | 122 | 87 | 80 | 69 | 133 | 105 | 79 | 146 | 99 | 91 |
| Cash conversion cycle | 106 | 78 | 38 | 55 | 61 | 52 | 65 | 56 | 39 | 33 | 58 | 36 |
| Working capital days | −33 | −79 | −56 | −33 | 0 | −3 | 16 | 18 | 5 | −10 | −23 | −39 |
| ROCE % | 6.0% | 6.0% | 11.0% | 17.0% | 25.0% | 16.0% | 17.0% | 18.0% | 17.0% | 14.0% | 12.0% | 8.0% |
For the Jun 2026 quarter, PCBL Chemical reported sales of ₹2,465 Cr, up 17.0% year on year and net profit of ₹155 Cr, up 64.9% year on year. The operating margin was 16.0%.
PCBL Chemical's sales for the year to Mar 2026 were ₹8,167 Cr; over the last twelve months they were ₹8,527 Cr.
Net profit for the year to Mar 2026 was ₹198 Cr, and ₹259 Cr over the last twelve months. Earnings per share over the same trailing period were ₹6.69.
PCBL Chemical reported borrowings of ₹4,992 Cr at Mar 2026, against cash and equivalents of ₹288 Cr.
Cash from operations was ₹1,575 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹850 Cr.